Is Quince Therapeutics, Inc. (QNCX) overvalued? · $79.3M cap
Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.
This page asks whether Quince Therapeutics, Inc. (QNCX) looks expensive on cached numbers — not a short thesis.
No cached income statement for QNCX, so there is no earnings base to call rich or cheap.
QNCX currently screens at market cap $79.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next QNCX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the QNCX stock page for the full model, not this heading.
Not investment advice.